Brazil probes vaccine contract with India’s Bharat Biotech
Prosecutors cite the drug's high price, speedy talks and pending regulatory approvals as red flags for the contract.Prosecutors cite the drug's high price, speedy talks and pending regulatory approvals as red flags for the contract.